CQDM is proud to announce a new collaboration / broadcast / communication partnership with OBIO.

CQDM. We collaborate.Always with the aim of facilitating and consolidating biopharma innovation in Quebec’s ecosystem and beyond, CQDM is proud to announce a new collaboration / broadcast / communication partnership with Ontario Bioscience Innovation Organization (OBIO).OBIO®, founded in 2009, is a not-for-profit, membership-based innovation organization engaged in strategy, programming, policy development and advocacy to further…

We need your precious collaboration

Notice to companies involved in biomanufacturing in Quebec.CQDM, in collaboration with the Quebec government, wishes to improve the biomanufacturing capacity applicable to RNA therapies of companies in Quebec. We need to understand your current service offering and what we could do to improve it.Please complete this short survey before September 29, 2023.Help us help you!…

QUO2 MRI: Quantitative Measurement of Metabolic and Vascular Anomalies in the Brain of Alzheimer’s Disease Patients

Challenge: The underlying causes of Alzheimer’s disease (AD) remain poorly understood, and only few dynamic biomarkers are available to monitor responses for experimental therapies. Neuroimaging methods such as structural magnetic resonance imaging (MRI) can detect brain atrophy, but slow changes during disease progression cannot be measured during the timeframe of clinical trials, while functional MRI (fMRI)…

In-vivo Solid Phase Microextraction Integrated with Mass Spectrometry Platform for Untargeted and Targeted Investigation of the Brain

Challenge: One of the major challenges currently faced by the pharmaceutical industry is the development of alternative approaches that allow the gathering of maximum information using a minimum number of animals. With regard to analytical instruments, mass spectrometers offer increasingly sensitive and quantitative determination of biological molecules. However, collected biological samples, especially tissues, require efficient…

Congratulations Sandrine Campeau

Congrats Sandrine Campeau. CQDM is proud to announce the internal promotion of Sandrine Campeau as Administration Director. In her new role, Sandrine will assume responsibilities for the entire CQDM administration, such as HR, IT, governance, operational management and others. According to Alysia Melnychuk, CPA, her immediate superior: “Sandrine is the backbone that unites and supports…

Subscribe to our newsletters

Subscribe to our newsletters. Our September 18 newsletter was released this morning. Did you receive it? You can register here. In this edition: Connect-Pharma – connect with the world’s largest pharmaceutical companies during our pitch day, several job offers available at CQDM, appointment to our team, 4,000 LinkedIn subscribers and various projects financed by CQDM.…

4,000 subscribers to our LinkedIn page

CQDM. We do it. We are very proud to announce that we have reached a “new peak”: 4,000 subscribers to our LinkedIn page! One more “level” reached in our quest to provide you with news and information relating to innovations in biopharmaceutical research, life sciences, pharmaceuticals and health. We also share CQDM and ecosystem news,…

Congrats Sandra!

CQDM. We grow.CQDM is proud to announce the internal promotion of Sandra Constantin as Program Manager and EDI Lead! In her new role, Sandra will ensure the efficient and rigorous management of CQDM funding programs (excluding the FACS program) as well as all projects in the portfolio. She will also continue to play her role…

Welcome Dorothy!

CQDM. We grow.CQDM is proud to announce the addition of a new member to its team! Welcome to Dorothy E. Josué, CPA who joins as Chief Accountant. Prior to her arrival, Dorothy was an accountant with Domtar in corporate accounting. She also began her career as an assistant accountant with a Quebec family business.After obtaining…